Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
42.1 SEK | +0.24% | -1.86% | +5.25% |
Business Summary
Number of employees: 26
Managers
Managers | Title | Age | Since |
---|---|---|---|
Per Andersson
CEO | Chief Executive Officer | 57 | 06-08-31 |
Director of Finance/CFO | 52 | Feb. 07 | |
Thomas Walz
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Chief Tech/Sci/R&D Officer | 60 | 17-12-31 | |
Investor Relations Contact | 63 | 19-05-14 | |
Sales & Marketing | - | 22-03-14 | |
Andreas Konar
PRN | Corporate Officer/Principal | 75 | 09-12-31 |
Edward Jordan
PRN | Corporate Officer/Principal | 55 | 23-09-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 14-12-31 | |
Carl-Johan Spak
BRD | Director/Board Member | 68 | 14-12-31 |
Chairman | 70 | 22-05-18 | |
Director/Board Member | 55 | 16-12-31 | |
Christine Lind
BRD | Director/Board Member | 50 | 18-12-31 |
Director/Board Member | 66 | 20-12-31 | |
Robert Molander
BRD | Director/Board Member | 59 | 22-05-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,253,542 | 16,001,596 ( 51.20 %) | 0 | 51.20 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.25% | 123M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Xspray Pharma AB - Nasdaq Stockholm
- Company Xspray Pharma AB